Comparing Strategies for Translating Self-management Support Into Primary Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus, Type 2
- Sponsor
- University of Colorado, Denver
- Enrollment
- 901
- Locations
- 1
- Primary Endpoint
- Change in LDL from baseline to 18 months
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This project will test different ways of helping primary care practices to do a better job of self-management support (SMS) for their patients with diabetes.
Detailed Description
The specific aims of the proposed study are: * Primary Specific Aims 1. To conduct a cluster randomized trial to examine the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) of Connection to Health (CTH) for patients with type 2 diabetes in primary care practice settings. Primary effectiveness outcomes will include hemoglobin A1c, Body Mass Index (BMI), blood pressure and Low Desity Lipprotein (LDL) cholesterol. 2. To determine the incremental benefit, using the RE-AIM framework, of brief targeted practice coaching on the implementation of CTH in diverse primary care practices. * Secondary Specific Aims 1. To identify key practice characteristics (e.g., practice size, organization, setting, and level of experience with practice redesign efforts) that impact CTH RE-AIM. These results will inform dissemination of the CTH intervention. 2. To determine the relative costs associated with implementing CTH and practice coaching to further inform dissemination efforts.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 21 years old or over
- •Type 2 Diabetes Mellitus diagnosed for a minimum of 12 months
- •Able to read in English or Spanish
- •Plan to remain in the practice during the study period
Exclusion Criteria
- •Developmentally disabled
- •Decisionally challenged
- •Pregnant women
Outcomes
Primary Outcomes
Change in LDL from baseline to 18 months
Time Frame: 18 months from baseline
Low-density lipoprotein (LDL) cholesterol will be measured at baseline and 18 months from baseline (in mg/dL; e.g., 160 mg/dL).
Change in HbA1c from baseline to 18 months
Time Frame: 18 months from baseline
Glycosylated hemoglobin (HbA1c) will be measured at baseline and 18 months from baseline.
Change in body mass index (BMI) from baseline to 18 months
Time Frame: 18 months from baseline
Body mass index (BMI) will be measured at baseline and 18 months from baseline (weight (kg) / \[height (m)\]2; e.g., 24.96)
Change in systolic and diastolic blood pressure from baseline to 18 months
Time Frame: 18 months from baseline
Systolic and diastolic blood pressure will be measured at baseline and 18 months from baseline (in mmHg; e.g., 140/90 mmHg)
Secondary Outcomes
- Evidence of documented self-management support for patients through medical record review(18 months from baseline)